Femasys Inc is trading 5.6% down at $0.35 after announcing a 1-for-20 reverse stock split intended to regain Nasdaq minimum bid compliance.
- The split will take effect after the market close on June 5, 2026, with split-adjusted trading scheduled to commence on June 8, 2026.
- Investors are reacting to potential dilution risks and the historical volatility often associated with reverse splits in the low-priced biotech sector.